ACA vs GE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to confirm safety from distress. Despite strong recent earnings growth (YoY EPS +71.4%, Earnings Growth YoY +335.3%) and solid revenue momentum (24.60% YoY), elevated valuation metrics (P/E 38.61 vs. sector avg 55.59) and bearish insider activity weigh on near-term outlook. The stock trades significantly above the Graham Number of $59.01, suggesting overvaluation for defensive investors, though growth investors may justify the premium. Analysts maintain a strong_buy consensus, but insider selling and modest dividend strength temper enthusiasm.
GE shows neutral fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
ACA vs GE: Head-to-Head Comparison
This page compares Arcosa, Inc. (ACA) and GE Aerospace (GE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.